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Abstract
Objective The extent to which neoadjuvant chemoradio-
therapy for rectal cancer influences postoperative morbid-
ity is controversial. This study investigated whether this
treatment suppresses the normal perioperative inflamma-
tory response and explored the clinical implications.
Method Prospective databases were queried to identify
37 consecutive study patients undergoing definitive
surgery following 5-FU ⁄ capecitabine-based chemoradio-
therapy and 35 consecutive untreated control patients
operated upon for rectal or rectosigmoid cancer. Preop-
erative (< 10 days) and postoperative (< 24 h) neutrophil
counts, along with morbidity data, were confirmed
retrospectively. Univariate and multivariate analyses
assessed the apparent effect of chemoradiotherapy on
change in neutrophil count. The latter’s association with
postoperative morbidity was then examined.
Results Sufficient data were available for 34 study and
27 control patients. Repeated-measures ANCOVA
revealed significant differences between their periopera-
tive neutrophil counts (P = 0.02). Of the other charac-
teristics which differed between the groups, only age
and tumour location were prognostically significant
regarding perioperative change in neutrophil count.
Accounting for relevant covariates, chemoradiotherapy
was significantly associated with a suppressed perioper-
ative neutrophil leucocytosis. Local postoperative com-
plications affected 25 of 61 patients, who had lower
perioperative neutrophil increases than their counter-
parts (P = 0.016).
Conclusion Chemoradiotherapy appears to suppress the
perioperative inflammatory response, thereby increasing
susceptibility to local postoperative complications.
Keywords Rectal cancer, neoadjuvant chemoradio-
therapy, surgery, postoperative complications, immuno-
suppression, leucocyte
Introduction
Meticulous surgical dissection along embryological
planes represents the mainstay of treatment for resectable
rectal cancer, but significant recurrence rates with
surgery alone and advances in imaging techniques have
contributed to the rationale for preoperative therapy.
Neoadjuvant radiotherapy has been demonstrated to
improve local control and overall survival and the
addition of chemotherapy reduces local recurrence
further [1].
Short-course radiotherapy, delivered over 1 week and
followed by surgery a few days later, increases postoper-
ative morbidity [2–5]. The extent to which this also
applies to chemoradiotherapy, typically administered over
5 weeks and followed by surgery several weeks later, is
more controversial. It is theoretically plausible that the
combined myelosuppressive effects of chemotherapy and
pelvic radiotherapy attenuate the normal inflammatory
response to surgical trauma, thereby increasing suscepti-
bility to complications. Objective evidence of immuno-
suppression at the time of surgery following
chemoradiotherapy for rectal cancer has been reported
previously, but any correlation with clinical morbidity
was not investigated [6]. However, among patients
treated with short-course radiotherapy, a suppressed
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postoperative neutrophil leucocytosis appears to predict
postoperative morbidity [7].
The purpose of this study was to investigate whether
the normal postoperative neutrophil leucocytosis follow-
ing chemoradiotherapy and delayed surgery is: (i) sup-
pressed; (ii) associated with local postoperative
complications; and (iii) related to the time interval to
surgery.
Method
Extensive data on all rectal cancer patients treated with
neoadjuvant chemoradiotherapy and definitive surgery at
Barnet Hospital have been prospectively collected since
1994. The 37 most recently and consecutively treated
patients were selected from this database as the study
group. A control group of 34 consecutive patients
undergoing elective surgery for cancer of the rectum or
rectosigmoid without neoadjuvant therapy was identified
from a second prospectively compiled database of all
colorectal cancer patients diagnosed since 2006. The use
of all data for the purposes of this study was approved by
the local research ethics committee.
For all patients, local staging was based on a combi-
nation of clinical assessment and pelvic magnetic reso-
nance imaging (MRI), while distant metastases were
excluded by computed tomography (CT) of abdomen
and thorax. Treatment was recommended to patients in
light of discussion by a multidisciplinary team, compris-
ing surgeons, oncologists, radiologists and pathologists.
Eligibility criteria for neoadjuvant chemoradiotherapy
included histologically confirmed rectal adenocarcinoma
involving or threatening the anticipated resection margin,
World Health Organisation (WHO) performance status
0–2 and acceptable haematological and renal function,
i.e. neutrophils > 1.5 · 109 ⁄ l, platelets ‡ 100 · 109 ⁄ l
and serum creatinine < 1.25 times the institution’s upper
limit of normal range.
Megavoltage external beam radiotherapy was deliv-
ered using a three- or four-field box technique in the
prone position using CT-based three-dimensional plan-
ning. To derive a planning target volume, margins were
added to the gross tumour volume as follows: 3 cm
laterally, superiorly and inferiorly; 2 cm anteriorly. The
posterior border was always located on the most posterior
aspect of the bony sacrum. All study patients received a
total of 45 Gy, delivered in 25 daily fractions of 1.8 Gy
over 33 days.
Concurrent chemotherapy was in the form of 5-
fluorouracil (5-FU) or its oral equivalent capecitabine.
The former was usually administered as a 60-min infusion
at a dose of 350 mg ⁄m2, along with 20 mg ⁄m2 folinic
acid, on each of the first five and last 5 days of
radiotherapy. Alternatively, a prolonged venous infusion
of 5-FU was administered at a daily dose of 200 mg ⁄m2
for the entire duration of radiotherapy and for 3 weeks
beyond. Capecitabine was prescribed at a twice daily dose
of 850 mg ⁄m2 during each day of radiotherapy.
Local protocol recommended that surgery be sched-
uled for 6–12 weeks following completion of radiother-
apy. In practice, patients were usually assessed at 6 weeks
by the operating surgeon, who decided whether to allow
additional time for tumour shrinkage. Surgery was
performed by, or under the direct supervision of, one
of four consultant surgeons with colorectal expertise,
who routinely carried out total mesorectal excision.
Surgical specimens were examined grossly and micro-
scopically using TNM criteria, according to the Royal
College of Pathologists’ minimum dataset for colorectal
cancer [8]. All lymph nodes retrieved were examined
histologically and any extramural deposits larger than
3 mm in diameter were considered to be nodal. Patients
were usually reviewed by the surgical team within 6 weeks
of their operation. For the purposes of this study,
complete wound healing was defined as intact skin with
no evidence of erythema, tenderness, fluctuance, dis-
charge or a sinus. Anastomotic leakage was diagnosed on
the basis of intra-operative findings, or clinically directed
imaging alone if laparotomy was not performed.
Neutrophil counts were obtained retrospectively from
the hospital’s laboratory computer system. Preoperative
counts were defined as having been collected within
10 days prior to surgery, while postoperative neutrophil
counts were all collected on the first postoperative day.
The incidences of local postoperative complications,
namely delayed perineal wound healing, anastomotic
leakage and re-laparotomy for any other reason, were
confirmed by retrospective review of discharge letters and
outpatient correspondence. Patients were excluded from
subsequent analysis if neutrophil counts were not avail-
able from these specific times or if sufficient details of
their postoperative recovery could not be obtained.
Data were analysed using statistical software (SPSS
version 15, SPSS, USA2 ). Shapiro–Wilks tests assessed the
degree of normality for all baseline and outcome
variables. Depending on these, chi-square tests (for
categorical variables) and Mann–Whitney U-test, ANO-
VA or unpaired t-tests (for continuous data) were used to
assess differences between the chemoirradiated and
untreated patients. Effect sizes were measured using
Cohen’s d or Cramer’s u, depending on the variable type
and the comparison test used [9]. Correlation and
equivalency tests were used to study the prognostic value
of baseline variables in predicting changes in neutrophil
count and complications. Repeated-measures ANCOVA
models were developed incorporating relevant covariates
Suppression of the postoperative neutrophil leucocytosis1 S. F. Kerr et al.
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to study the association between chemoradiotherapy and
change in neutrophil count. Similarly, ANCOVA models
were developed to study the association between change
in neutrophil count and postoperative complications. The
association between change in neutrophil count and
interval length was assessed using unpaired t-tests.
Results
Sufficient data on perioperative neutrophil counts and
morbidity were available for 34 of 37 study patients and
27 of 34 control patients. Among the study patients, 19
had received oral capecitabine and 15 had received
intravenous 5-FU, of which the prolonged regimen
throughout the entire duration of radiotherapy and for
3 weeks beyond was administered to only two patients.
One study patient was treated for recurrent rectal
cancer; all other patients had primary disease. One patient
in each group underwent simultaneous cystoprostatecto-
my and urinary diversion, while two study and one
control patients underwent hysterectomy and bilateral
salpingo-oophorectomy. Other baseline, operative and
pathological characteristics for each of the groups are
shown in Table 1. Both preoperative and postoperative
neutrophil counts were approximately normally distrib-
uted.
Figure 1 portrays the perioperative change in neutro-
phil count for each group. Correlation and equivalency
tests determined that age, tumour distance from anal
verge and chemoradiotherapy were the only prognosti-
cally significant variables for this outcome. Although the
two groups’ preoperative neutrophil counts were similar,
repeated-measures ANCOVA revealed significant differ-
ences between study and control patients (P = 0.02),
with a marked effect size (g2 = 0.14) and observed power
(0.85). When relevant covariates were incorporated in
this ‘between-subjects’ comparison, neither age nor
tumour distance from anal verge had significant effects
(Table 2). Figure 2 portrays the perioperative increases in
neutrophil count in terms of estimated marginal means,
i.e. means after the covariates have been accounted for.
‘Within-subjects’ comparison tests confirmed a signif-
icant postoperative increase in neutrophil count, irre-
spective of group (Table 3). The interaction of
measurement points with the variables included in the
model did not reveal any significant differences for age or
distance, whereas chemoradiotherapy did appear to be a
major determinant of this increase (Figure 3).
Four patients died prior to discharge, including three
within 30 post-operative days; all four had experienced
anastomotic leakage. In total, seven of 26 anterior
resections were complicated by clinically apparent anas-
tomotic leakage. Two other patients with small bowel
obstruction, one with intra-abdominal haemorrhage and
one with a small intestinal fistula required re-laparotomy
prior to discharge. Complete perineal healing was not
achieved by 6 weeks following 16 of 30 abdominoperi-
neal resections.
In total, 25 of 61 (41.0%) patients experienced at least
one of these local postoperative complications. Their
preoperative neutrophil counts were similar to those of
Table 1 Baseline, operative and patho-
logical characteristics.
Study
(n = 34)
Control
(n = 27) P-value
Effect
size*
Male 19 20 0.14 0.19
Age (years) 62.3 ± 2.1 73.6 ± 2.1 0.004 0.84
Distance from anal verge (cm) 4.3 ± 0.2 11.0 ± 0.9 < 0.001 1.62
AR:APR:Hartmann’s 6:26:2 20:4:3 < 0.001 0.86
Laparoscopic 0 8 < 0.001 0.43
(y)T3–4 18 20 0.09 0.70
Preop neutrophil count (·109 ⁄ l) 4.26 ± 0.41 4.42 ± 0.50 0.64 0.15
Continuous data presented as mean ± SE.
*Calculated as Cohen’s d and Cramer’s u, for continuous and categorical variables,
respectively.
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Figure 1 Perioperative neutrophil counts.
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their 36 counterparts, with means of 4.5 · 109 ⁄ l and
4.2 · 109 ⁄ l respectively (P = 0.348). Mean perioperative
increases in neutrophil count were 3.0 · 109 ⁄ l and
4.7 · 109 ⁄ l respectively (P = 0.016). With ANCOVA,
the association between change in neutrophil count and
complications failed to reach statistical significance
(P = 0.09), although the effect size was moderate
(g2 = 0.05),
For the 34 study patients, the median interval from
completion of radiotherapy to surgery was 74.5 (range
50–118) days. This value was used to divide these
patients into two equally sized groups. Mean preoperative
neutrophil count was 4.3 · 109 ⁄ l for the short interval
group and 4.2 · 109 ⁄ l for the long interval group
(P = 0.747). Mean perioperative increases in neutrophil
count were 3.1 · 109 ⁄ l and 3.2 · 109 ⁄ l respectively
(P = 0.905).
Discussion and conclusions
At present, it is difficult to determine from the literature
the extent to which neoadjuvant chemoradiotherapy for
rectal cancer influences postoperative morbidity. Most of
the large randomized trials of short-course radiotherapy
have demonstrated a detrimental effect of this regimen,
particularly with respect to perineal wound healing [2–5].
In turn, three randomized trials of preoperative chemor-
adiotherapy vs short-course radiotherapy have reported
that the rates of postoperative complications were not
significantly different between the two regimens [10–12].
Combined modality treatment has also been implicated as
a cause of surgical morbidity by some retrospective
analyses [13–15]. By contrast, the only completed
randomized trial of preoperative vs postoperative che-
moradiotherapy reported no significant difference in
postoperative morbidity between the two groups [16].
However, it is possible that a true detrimental effect of
chemoradiotherapy per se was obscured by the fact that
this treatment caused down-staging and altered the
operative strategy in some patients.
This study provides evidence that neoadjuvant che-
moradiotherapy for rectal cancer suppresses the normal
inflammatory response to surgical trauma, as measured by
the postoperative neutrophil leucocytosis, even at a
median of 11 weeks following treatment completion.
This is broadly consistent with Wichmann et al.’s pro-
spective study, in which various inflammatory and
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Figure 2 Estimated marginal means of perioperative neutrophil
counts.
Table 3 Tests of ‘within-subjects’ effects (*computed using
alpha = 0.05).
Source df F P-value g2
Observed
power*
Neutrophil increase 1 11.641 0.001 0.17 0.92
Distance 1 0.172 0.680 0.003 0.07
Age 1 2.009 0.162 0.04 0.29
Chemoradiotherapy 1 6.236 0.015 0.10 0.69
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Figure 3 Estimated marginal means of change in neutrophil
count.
Table 2 Tests of ‘between-subjects’ effects (*computed using
alpha = 0.05).
Source df F P-value g2
Observed
power*
Intercept 1 35.608 0.000 0.39 1.00
Distance 1 0.825 0.367 0.02 0.15
Age 1 0.037 0.848 0.001 0.05
Chemoradiotherapy 1 6.255 0.015 0.10 0.69
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immunological markers were suppressed perioperatively
among 15 rectal cancer patients treated with chemora-
diotherapy in comparison with 15 matched controls [6].
Their discrepant finding that preoperative granulocyte
count also differed significantly between the two groups
may be due to the fact that their patients proceeded to
surgery within a shorter interval of 4–6 weeks. Differ-
ences in the perioperative changes in granulocyte count
between the two groups were not reported in their study
and the implications for clinical morbidity were not
investigated.
This study also found evidence of a suppressed
postoperative neutrophil leucocytosis among those pa-
tients subsequently developing local postoperative com-
plications in comparison with their counterparts who had
uncomplicated recoveries. This resembles Hartley et al.’s
experience with short-course preoperative radiotherapy
[7]. Although this secondary association lost statistical
significance on multivariate analysis, this may simply
reflect the small sample size, particularly as there was
a moderate effect size. A larger series of patients would
be required to explore satisfactorily the clinical
significance of any myelosuppressive effect of
chemoradiotherapy.
The findings of any small study such as this should be
interpreted with caution, as it is possible that they could
have arisen by chance. Much of the principal data were
collected retrospectively and, although consecutive pa-
tients were recruited to minimize selection bias, some
were subsequently excluded due to incomplete data.
Perhaps its main limitation is that the study and control
patients were not optimally matched: for example, the
former were younger and had lower rectal tumours and
two factors which would have contributed to their
selection for neoadjuvant therapy. However, the statisti-
cal analysis suggests that the apparent effect of chemor-
adiotherapy is unlikely to be attributable to any of the
other observed differences between the groups.
Although pathological tumour stage was similar
between the groups, the study patients might have had
considerably larger tumours prior to treatment, which
one might speculate could have contributed to immu-
nosuppression. It could also be argued that each of the
patient groups was rather heterogeneous: for example, all
the study patients did not receive exactly the same
chemotherapeutic regimen. A few patients underwent
synchronous resection of adjacent organs, but they were
at least evenly distributed between the groups. The single
measurements of wound healing and postoperative neu-
trophil count are rather crude outcome data, albeit
consistently collected. Finally, the relatively high rate of
anastomotic leakage may simply reflect the small sample
size and has broad confidence intervals.
It might have been expected that the chemoradio-
therapy-induced suppression of the postoperative neu-
trophil leucocytosis would have become less pronounced
with longer intervals to surgery, as the bone marrow
recovered. This could have provided one explanation for
the positive association between shorter intervals and
postoperative morbidity reported recently by the authors
[17]. Although no such influence of interval length was
apparent in this study, a definitive exploration of this
hypothesis would require a larger series of patients.
In summary, neoadjuvant chemoradiotherapy is
increasingly employed in the management of rectal cancer
but its implications for surgical morbidity remain con-
troversial. Consistent with the limited available evidence,
this study suggests that the normal perioperative inflam-
matory response is suppressed by this treatment, increas-
ing susceptibility to local postoperative complications.
Further research is needed to ensure that patients with
rectal cancer derive the optimal long-term oncological
benefit of chemoradiotherapy at minimal cost to their
prospects of an uncomplicated postoperative recovery.
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